These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29964227)

  • 1. Efficacy of C1 inhibitor concentrate in hereditary angioedema with C1 inhibitor deficiency: Analysis in a French cohort.
    Belbézier A; Boccon-Gibod I; Thanh AD; Fain O; Bouillet L;
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):506-508. PubMed ID: 29964227
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost.
    Rasmussen ER; Aagaard L; Bygum A
    Ann Allergy Asthma Immunol; 2016 May; 116(5):476-7. PubMed ID: 27017563
    [No Abstract]   [Full Text] [Related]  

  • 3. Hereditary angioedema--therapies old and new.
    Morgan BP
    N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
    Stehlin F; Ribi C
    Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema.
    Hakl R; Kuklínek P; Sobotková M; Krčmová I; Králíčková P; Vachová M; Hanzlíková J; Nováčková M; Svoboda M; Kováčová I; Litzman J
    Clin Exp Allergy; 2022 Aug; 52(8):994-997. PubMed ID: 35662289
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic agents for hereditary angioedema.
    Giavina-Bianchi P; Motta A; Kalil J
    N Engl J Med; 2011 Jan; 364(1):85; author reply 86. PubMed ID: 21208116
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.
    Firinu D; Barca MP; Serusi L; Lorrai MM; Peralta MM; Manconi PE; Del Giacco SR
    Int J Immunopathol Pharmacol; 2012; 25(1):269-73. PubMed ID: 22507340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
    Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
    Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.
    Cicardi M; Bork K; Caballero T; Craig T; Li HH; Longhurst H; Reshef A; Zuraw B;
    Allergy; 2012 Feb; 67(2):147-57. PubMed ID: 22126399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary angioedema--treatment].
    Muszyńska A; Fal AM
    Pol Merkur Lekarski; 2008 Jul; 25(145):94-6. PubMed ID: 18839625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Treatments for Hereditary Angioedema.
    Johnson NM; Phillips MA
    Skin Therapy Lett; 2018 Jan; 23(1):6-8. PubMed ID: 29357215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary angioedema: a case series and bibliographic update].
    Becerra AL; Morales DV
    Rev Alerg Mex; 2009; 56(2):48-55. PubMed ID: 19526954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Incidence and Frequency of Various Causes of Angioedema in Emergency Medicine.
    Karadža-Lapić L; Pikivaca T; Pervan P; Jović Zlatović J; Delin S; Prkačin I
    Acta Med Acad; 2018 May; 47(1):11-17. PubMed ID: 29957967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week.
    Bork K; Hardt J
    Int Arch Allergy Immunol; 2011; 154(1):81-8. PubMed ID: 20664282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States.
    Tachdjian R; Johnson KE; Casso D; Oliveria SA; Devercelli G; Jain G
    Allergy Asthma Proc; 2020 May; 41(3):172-182. PubMed ID: 32375961
    [No Abstract]   [Full Text] [Related]  

  • 19. The Role of Complement in Hereditary Angioedema.
    Levi M; Cohn DM
    Transfus Med Rev; 2019 Oct; 33(4):243-247. PubMed ID: 31676220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological therapy in hereditary angioedema: transformation of a rare disease.
    Longhurst H; Farkas H
    Expert Opin Biol Ther; 2020 May; 20(5):493-501. PubMed ID: 31994957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.